ArticleTranslational vision science & technology2021
Automated Identification of Referable Retinal Pathology in Teleophthalmology Setting.
Article in Translational vision science & technology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 5 citations in OpenAlex.
- RobOCTNet: Robotics and Deep Learning for Referable Posterior Segment Pathology Detection in an Emergency Department Population.Translational vision science & technology · 2024Article
- The Present and Future of Artificial Intelligence-Based Medical Image in Diabetes Mellitus: Focus on Analytical Methods and Limitations of Clinical Use.Journal of Korean medical science · 2023Review
- Gradient Importance Learning for Incomplete Observations.... International Conference on Learning Representations · 2022Article
- Deep Learning Models for Segmenting Non-perfusion Area of Color Fundus Photographs in Patients With Branch Retinal Vein Occlusion.Frontiers in medicine · 2022Article
- Incidence of Referable Retinal Disease in Diabetic Patients at a Primary Care Practice.Journal of vitreoretinal diseasesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aims to meet a growing need for a fully automated, learning-based interpretation tool for retinal images obtained remotely (e.g. teleophthalmology) through different imaging modalities that may include imperfect (uninterpretable) images. Methods: A retrospective study of 1148 optical coherence tomography (OCT) and color fundus photography (CFP) retinal images obtained using Topcon's Maestro care unit on 647 patients with diabetes. To identify retinal pathology, a Convolutional Neural Network (CNN) with dual-modal inputs (i.e. CFP and OCT images) was developed. We developed a novel alternate gradient descent algorithm to train the CNN, which allows for the use of uninterpretable CFP/OCT images (i.e. ungradable images that do not contain sufficient image biomarkers for the reviewer to conclude absence or presence of retinal pathology). Specifically, a 9:1 ratio to split the training and testing dataset was used for training and validating the CNN. Paired CFP/OCT inputs (obtained from a single eye of a patient) were grouped as retinal pathology negative (RPN; 924 images) in the absence of retinal pathology in both imaging modalities, or if one of the imaging modalities was uninterpretable and the other without retinal pathology. If any imaging modality exhibited referable retinal pathology, the corresponding CFP/OCT inputs were deemed retinal pathology positive (RPP; 224 images) if any imaging modality exhibited referable retinal pathology. Results: Our approach achieved 88.60% (95% confidence interval [CI] = 82.76% to 94.43%) accuracy in identifying pathology, along with the false negative rate (FNR) of 12.28% (95% CI = 6.26% to 18.31%), recall (sensitivity) of 87.72% (95% CI = 81.69% to 93.74%), specificity of 89.47% (95% CI = 83.84% to 95.11%), and area under the curve of receiver operating characteristic (AUC-ROC) was 92.74% (95% CI = 87.71% to 97.76%). Conclusions: Our model can be successfully deployed in clinical practice to facilitate automated remote retinal pathology identification. Translational Relevance: A fully automated tool for early diagnosis of retinal pathology might allow for earlier treatment and improved visual outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.